APTOCROM Inc. (KOSDAQ:109960)

South Korea flag South Korea · Delayed Price · Currency is KRW
270.00
+3.00 (1.12%)
At close: Dec 5, 2025
-36.62%
Market Cap61.81B
Revenue (ttm)12.15B
Net Income (ttm)-66.83B
Shares Out220.75M
EPS (ttm)-344.36
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume600,080
Average Volume414,376
Open267.00
Previous Close267.00
Day's Range266.00 - 274.00
52-Week Range258.00 - 654.00
Beta-0.11
RSI50.46
Earnings DateNov 13, 2025

About APTOCROM

APTOCROM Inc. distributes pharmaceutical products in South Korea. It offers prescription and over-the-counter medication, such as antibiotics, antifungal agent, antiviral drugs, infusion solution, peptic ulcer medication, osteoarthritis treatment, purifying solvent, brain function improvement agent, respiratory solvent, topical medicine, adrenocorticosteroids, urinary medicine, hair loss treatment, antipyretic analgesic and anti-inflammatory agent, antihistamines, obesity agents, neural contract, liver extract, fire extinguisher solvent, etc. T... [Read more]

Industry Drugs, Drug Proprietaries, and Druggists' Sundries
Founded 1998
Employees 14
Stock Exchange KOSDAQ
Ticker Symbol 109960
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.